208 related articles for article (PubMed ID: 35922651)
1. ADAR3 activates NF-κB signaling and promotes glioblastoma cell resistance to temozolomide.
Raghava Kurup R; Oakes EK; Vadlamani P; Nwosu O; Danthi P; Hundley HA
Sci Rep; 2022 Aug; 12(1):13362. PubMed ID: 35922651
[TBL] [Abstract][Full Text] [Related]
2. Adenosine Deaminase That Acts on RNA 3 (ADAR3) Binding to Glutamate Receptor Subunit B Pre-mRNA Inhibits RNA Editing in Glioblastoma.
Oakes E; Anderson A; Cohen-Gadol A; Hundley HA
J Biol Chem; 2017 Mar; 292(10):4326-4335. PubMed ID: 28167531
[TBL] [Abstract][Full Text] [Related]
3. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J
Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149
[TBL] [Abstract][Full Text] [Related]
4. Smac mimetic sensitizes glioblastoma cells to Temozolomide-induced apoptosis in a RIP1- and NF-κB-dependent manner.
Wagner L; Marschall V; Karl S; Cristofanon S; Zobel K; Deshayes K; Vucic D; Debatin KM; Fulda S
Oncogene; 2013 Feb; 32(8):988-97. PubMed ID: 22469979
[TBL] [Abstract][Full Text] [Related]
5. Temozolomide Treatment Induces lncRNA MALAT1 in an NF-κB and p53 Codependent Manner in Glioblastoma.
Voce DJ; Bernal GM; Wu L; Crawley CD; Zhang W; Mansour NM; Cahill KE; Szymura SJ; Uppal A; Raleigh DR; Spretz R; Nunez L; Larsen G; Khodarev NN; Weichselbaum RR; Yamini B
Cancer Res; 2019 May; 79(10):2536-2548. PubMed ID: 30940658
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional control of O
Happold C; Stojcheva N; Silginer M; Weiss T; Roth P; Reifenberger G; Weller M
J Neurochem; 2018 Mar; 144(6):780-790. PubMed ID: 29480969
[TBL] [Abstract][Full Text] [Related]
7. RNA binding candidates for human ADAR3 from substrates of a gain of function mutant expressed in neuronal cells.
Wang Y; Chung DH; Monteleone LR; Li J; Chiang Y; Toney MD; Beal PA
Nucleic Acids Res; 2019 Nov; 47(20):10801-10814. PubMed ID: 31552420
[TBL] [Abstract][Full Text] [Related]
8. NF-κB induces miR-148a to sustain TGF-β/Smad signaling activation in glioblastoma.
Wang H; Pan JQ; Luo L; Ning XJ; Ye ZP; Yu Z; Li WS
Mol Cancer; 2015 Feb; 14():2. PubMed ID: 25971746
[TBL] [Abstract][Full Text] [Related]
9. Tumor-derived fibulin-3 activates pro-invasive NF-κB signaling in glioblastoma cells and their microenvironment.
Nandhu MS; Kwiatkowska A; Bhaskaran V; Hayes J; Hu B; Viapiano MS
Oncogene; 2017 Aug; 36(34):4875-4886. PubMed ID: 28414309
[TBL] [Abstract][Full Text] [Related]
10. Sulforaphane reverses chemo-resistance to temozolomide in glioblastoma cells by NF-κB-dependent pathway downregulating MGMT expression.
Lan F; Yang Y; Han J; Wu Q; Yu H; Yue X
Int J Oncol; 2016 Feb; 48(2):559-68. PubMed ID: 26648123
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic TRADD confers a worse prognosis in glioblastoma.
Chakraborty S; Li L; Tang H; Xie Y; Puliyappadamba VT; Raisanen J; Burma S; Boothman DA; Cochran B; Wu J; Habib AA
Neoplasia; 2013 Aug; 15(8):888-97. PubMed ID: 23908590
[TBL] [Abstract][Full Text] [Related]
12. Aberrant constitutive activation of nuclear factor kappaB in glioblastoma multiforme drives invasive phenotype.
Raychaudhuri B; Han Y; Lu T; Vogelbaum MA
J Neurooncol; 2007 Oct; 85(1):39-47. PubMed ID: 17479228
[TBL] [Abstract][Full Text] [Related]
13. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
Guo G; Sun Y; Hong R; Xiong J; Lu Y; Liu Y; Lu J; Zhang Z; Guo C; Nan Y; Huang Q
Clin Transl Oncol; 2020 Aug; 22(8):1252-1262. PubMed ID: 31865606
[TBL] [Abstract][Full Text] [Related]
14. A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains.
Chen CX; Cho DS; Wang Q; Lai F; Carter KC; Nishikura K
RNA; 2000 May; 6(5):755-67. PubMed ID: 10836796
[TBL] [Abstract][Full Text] [Related]
15. Identification of non-canonical NF-κB signaling as a critical mediator of Smac mimetic-stimulated migration and invasion of glioblastoma cells.
Tchoghandjian A; Jennewein C; Eckhardt I; Rajalingam K; Fulda S
Cell Death Dis; 2013 Mar; 4(3):e564. PubMed ID: 23538445
[TBL] [Abstract][Full Text] [Related]
16. CRB2 enhances malignancy of glioblastoma via activation of the NF-κB pathway.
Wang Y; Bao G; Zhang M; Xiang J; Zhou H; Wahafu A; Wu W; Ma X; Huo L; Bai X; Xie W; Liu P; Wang M
Exp Cell Res; 2022 May; 414(1):113077. PubMed ID: 35219647
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistance.
Tanaka K; Babic I; Nathanson D; Akhavan D; Guo D; Gini B; Dang J; Zhu S; Yang H; De Jesus J; Amzajerdi AN; Zhang Y; Dibble CC; Dan H; Rinkenbaugh A; Yong WH; Vinters HV; Gera JF; Cavenee WK; Cloughesy TF; Manning BD; Baldwin AS; Mischel PS
Cancer Discov; 2011 Nov; 1(6):524-38. PubMed ID: 22145100
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of NF-κB results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression.
Yu Z; Chen Y; Wang S; Li P; Zhou G; Yuan Y
Cancer Lett; 2018 Aug; 428():77-89. PubMed ID: 29705182
[TBL] [Abstract][Full Text] [Related]
19. The prolyl isomerase Pin1 regulates the NF-kappaB signaling pathway and interleukin-8 expression in glioblastoma.
Atkinson GP; Nozell SE; Harrison DK; Stonecypher MS; Chen D; Benveniste EN
Oncogene; 2009 Oct; 28(42):3735-45. PubMed ID: 19668231
[TBL] [Abstract][Full Text] [Related]
20. SGEF Is Regulated via TWEAK/Fn14/NF-κB Signaling and Promotes Survival by Modulation of the DNA Repair Response to Temozolomide.
Ensign SP; Roos A; Mathews IT; Dhruv HD; Tuncali S; Sarkaria JN; Symons MH; Loftus JC; Berens ME; Tran NL
Mol Cancer Res; 2016 Mar; 14(3):302-12. PubMed ID: 26764186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
